ATS Automation
ATA-T
43 watching
About ATS Automation (ATA-T)
0
0
0
0
0
Your Reaction
They do tooling for factories. Manufacturing is moving to e-vehicles and more automation in factories. ATS can do this. Backlog is growing and just bought a company today. High valuation. Sound strategy. He has a 5-year timeline for ATS. Things are playing out well for them. Likes it.
They do tooling for factories. Manufacturing is moving to e-vehicles and more automation in factories. ATS can do this. Backlog is growing and just bought a company today. High valuation. Sound strategy. He has a 5-year timeline for ATS. Things are playing out well for them. Likes it.
This is one of his biggest positions. They report growth quarter after quarter. They were a challenged company but they changed management, changed focus to health care sector and cleaned up the balance sheet. They have no net debt. The stock has had a big run-up but the fundamentals have been going up at least as fast. It trades at a discount to US peers even though it has a much better balance sheet. It trades at about 12x EBITDA and peers trade in the mid-teens.
This is one of his biggest positions. They report growth quarter after quarter. They were a challenged company but they changed management, changed focus to health care sector and cleaned up the balance sheet. They have no net debt. The stock has had a big run-up but the fundamentals have been going up at least as fast. It trades at a discount to US peers even though it has a much better balance sheet. It trades at about 12x EBITDA and peers trade in the mid-teens.
They design and build turnkey manufacturing and test systems. Doesn’t pay a dividend, but he thinks it is coming out of a long sleep with great opportunities as many companies bring manufacturing back to North America. They had a big earnings surprise this quarter and analysts’ forecasts have been revised significantly upward. Looking at the technical pattern, he thinks there is a possible 50% upside. (Analysts’ price target is $22.40)
They design and build turnkey manufacturing and test systems. Doesn’t pay a dividend, but he thinks it is coming out of a long sleep with great opportunities as many companies bring manufacturing back to North America. They had a big earnings surprise this quarter and analysts’ forecasts have been revised significantly upward. Looking at the technical pattern, he thinks there is a possible 50% upside. (Analysts’ price target is $22.40)
They create automated liines for medical and small packaging. It's a cyclical stock, following the industrial cycle. But over the long term it has a future. They face competition from Chinese automation companies. A decent company and good business.
They create automated liines for medical and small packaging. It's a cyclical stock, following the industrial cycle. But over the long term it has a future. They face competition from Chinese automation companies. A decent company and good business.
Comments
00000
